GLP-1a: Going beyond Traditional Use
The loss of patent protections, the development of cheaper pill formats, and a focus on the previously discovered health benefits of semaglutide, like prevention of kidney and heart disease which will encourage more coverage from governments and insurers all point to the cost barrier weakening significantly in the near future
they are betting on its potential to become the central, integrated platform for a patients entire healthcare journey, a position that would command an immense and highly defensible lifetime value
A Victoza generic is available under the name liraglutide (FDA-approved on December 23, 2024)
Private prescription is an alternative route, though costs can be substantial, and patients should discuss availability and costs with their prescriber or pharmacist
Many people choose to take their semaglutide first thing in the morning